Moderna Cash from Financing (Quarterly) Analysis

Moderna Inc (MRNA)

41.11 +2.86 (+7.48%) USD | NASDAQ | Nov 22, 16:00

41.35 +0.24 (+0.58%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	11.00M
June 30, 2024	34.00M
March 31, 2024	14.00M
December 31, 2023	-109.00M
September 30, 2023	-58.00M
June 30, 2023	-668.00M
March 31, 2023	-542.00M
December 31, 2022	-438.00M
September 30, 2022	-1.041B
June 30, 2022	-1.327B
March 31, 2022	-642.00M
December 31, 2021	-873.00M
September 30, 2021	-2.00M
June 30, 2021	-24.00M

Date	Value
March 31, 2021	26.00M
December 31, 2020	44.00M
September 30, 2020	30.00M
June 30, 2020	1.381B
March 31, 2020	578.00M
December 31, 2019	31.72M
September 30, 2019	15.81M
June 30, 2019	4.177M
March 31, 2019	0.293M
December 31, 2018	575.92M
September 30, 2018	-9.43M
June 30, 2018	110.36M
March 31, 2018	550.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.327B

Minimum

Jun 2022

1.381B

Maximum

Jun 2020

-178.71M

Average

-13.00M

Median

Cash from Financing (Quarterly) Benchmarks

Eli Lilly and Co	211.30M
Merck & Co Inc	-2.425B
Pfizer Inc	-4.636B
Novavax Inc	-0.097M
Biogen Inc	-6.60M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-1.566B
Cash from Investing (Quarterly)	721.00M
Free Cash Flow	-3.956B
Free Cash Flow Per Share (Quarterly)	-4.303
Free Cash Flow to Equity (Quarterly)	-1.717B
Free Cash Flow to Firm (Quarterly)	-1.717B
Free Cash Flow Yield	-24.88%